Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05556525 · ClinicalTrials.gov registry record · NA

Needle-Based Confocal Laser Endomicroscopy for Diagnosis of Lung Cancer in Patients With Peripheral Pulmonary Nodules

A NA study, sponsored by Mayo Clinic.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT05556525: Clinical Trial NA study, sponsored by Mayo Clinic.

NCT05556525 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05556525, a NA study, was terminated before completion, sponsored by Mayo Clinic.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

This clinical trial compares the addition of needle-based confocal laser endomicroscopy (nCLE) and fluorescein to endobronchial ultrasound-guided transbronchial needle aspiration (EBUS TBNA) with EBUS TBNA alone for the diagnosis of lung cancer in patients with peripheral pulmonary nodules. EBUS TBNA is a diagnostic procedure that can be used to sample lung tissue. nCLE is a novel high-resolution imaging technique that uses a laser light to create real-time microscopic images of tissues. It can be integrated into needles allowing real-time cancer detection during endoscopy. Fluorescein is an imaging agent that can be used to visualize tissue. Using nCLE and fluorescein in combination with EBUS TBNA may be more effective in diagnosing lung cancer than using EBUS TBNA alone.

Interventions

  • PROCEDURE Ultrasound-Guided Transbronchial Needle Aspiration
  • OTHER Fluorescein
  • DEVICE Image-Guided Needle Confocal Laser Endomicroscopy

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2023-05-12
Est. Completion 2024-10-25
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05556525

The ClinicalTrials.gov registry entry for NCT05556525 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Ultrasound-Guided Transbronchial Needle Aspiration is the first listed.

NCT05556525 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05556525 about?

NCT05556525 is a clinical study titled "Needle-Based Confocal Laser Endomicroscopy for Diagnosis of Lung Cancer in Patients With Peripheral Pulmonary Nodules". This clinical trial compares the addition of needle-based confocal laser endomicroscopy (nCLE) and fluorescein to endobronchial ultrasound-guided transbronchial needle aspiration (EBUS TBNA) with EBUS TBNA alone for the diagnosis of lung cancer in patients with peripheral pulmonary nodules. EBUS TBN...

What is the current status of trial NCT05556525?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2023-05-12. Estimated completion is 2024-10-25.

What interventions are being tested in trial NCT05556525?

The interventions under investigation include: Ultrasound-Guided Transbronchial Needle Aspiration (PROCEDURE), Fluorescein (OTHER), Image-Guided Needle Confocal Laser Endomicroscopy (DEVICE).

Who is sponsoring clinical trial NCT05556525?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.